Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2000;59(Supplement 1 ):i6-i16; doi:10.1136/ard.59.suppl_1.i6
Copyright © 2000 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2000;59(Suppl 1):i6-i16 ( November )

Article

Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappa B Bharat B Aggarwal

Cytokine Research Laboratory, Department of Bioimmunotherapy, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, PO Box 143, Houston, Texas 77030, USA

Correspondence to: Dr Aggarwal (aggarwal{at}utmdacc.mda.uth.tmc.edu)

Tumour necrosis factor (TNF) is a pleiotropic cytokine that mediates apoptosis, cell proliferation, immunomodulation, inflammation, viral replication, allergy, arthritis, septic shock, insulin resistance, autoimmune diseases, and other pathological conditions. TNF transduces these cellular responses through two distinct receptors: type I, which are expressed on all cell types, and type II, which are expressed only on cells of the immune system and endothelial cells. At the cellular level, these receptors activate the pathways leading to the activation of transcription factors NF-kappa B and AP-1, apoptosis and proliferation, and mitogen activated protein kinases. None of these receptors exhibit any enzymatic activity but the signals are transmitted through the recruitment of more than a dozen different signalling proteins, which together form signalling cascades. Inhibitors of TNF signalling have therapeutic value as indicated by the approval of the soluble TNF receptors and anti-TNF antibodies for rheumatoid arthritis and for inflammatory bowl disease.


© 2000 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Lee, S-W, Kim, J-H, Park, Y-B, Lee, S-K (2009). Bortezomib attenuates murine collagen-induced arthritis. Ann Rheum Dis 68: 1761-1767 [Abstract] [Full Text]  
  • Kumar, M., Makonchuk, D. Y., Li, H., Mittal, A., Kumar, A. (2009). TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF-{beta}-Activated Kinase 1. J. Immunol. 182: 2439-2448 [Abstract] [Full Text]  
  • Hirose, O., Yoshida, R., Imoto, S., Yamaguchi, R., Higuchi, T., Charnock-Jones, D. S., Print, C., Miyano, S. (2008). Statistical inference of transcriptional module-based gene networks from time course gene expression profiles by using state space models. Bioinformatics 24: 932-942 [Abstract] [Full Text]  
  • Porath, D., Riegger, C., Drewe, J., Schwager, J. (2005). Epigallocatechin-3-gallate Impairs Chemokine Production in Human Colon Epithelial Cell Lines. J. Pharmacol. Exp. Ther. 315: 1172-1180 [Abstract] [Full Text]  
  • Zhang, J. Y., Tao, S., Kimmel, R., Khavari, P. A. (2005). CDK4 regulation by TNFR1 and JNK is required for NF-{kappa}B-mediated epidermal growth control. JCB 168: 561-566 [Abstract] [Full Text]  
  • Matsumoto, G., Namekawa, J.-i., Muta, M., Nakamura, T., Bando, H., Tohyama, K., Toi, M., Umezawa, K. (2005). Targeting of Nuclear Factor {kappa}B Pathways by Dehydroxymethylepoxyquinomicin, a Novel Inhibitor of Breast Carcinomas: Antitumor and Antiangiogenic Potential In vivo. Clin. Cancer Res. 11: 1287-1293 [Abstract] [Full Text]  
  • Kilpatrick, L. E., Sun, S., Korchak, H. M. (2004). Selective regulation by {delta}-PKC and PI 3-kinase in the assembly of the antiapoptotic TNFR-1 signaling complex in neutrophils. Am. J. Physiol. Cell Physiol. 287: C633-C642 [Abstract] [Full Text]  
  • Takada, Y., Aggarwal, B. B. (2004). TNF Activates Syk Protein Tyrosine Kinase Leading to TNF-Induced MAPK Activation, NF-{kappa}B Activation, and Apoptosis. J. Immunol. 173: 1066-1077 [Abstract] [Full Text]  
  • Zhang, J. Y., Green, C. L., Tao, S., Khavari, P. A. (2004). NF-{kappa}B RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 18: 17-22 [Abstract] [Full Text]  
  • Takada, Y., Aggarwal, B. B. (2003). Betulinic Acid Suppresses Carcinogen-Induced NF-{kappa}B Activation Through Inhibition of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Abrogation of Cyclooxygenase-2 and Matrix Metalloprotease-9. J. Immunol. 171: 3278-3286 [Abstract] [Full Text]  
  • Matussek, A., Lauber, J., Bergau, A., Hansen, W., Rohde, M., Dittmar, K. E. J., Gunzer, M., Mengel, M., Gatzlaff, P., Hartmann, M., Buer, J., Gunzer, F. (2003). Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 102: 1323-1332 [Abstract] [Full Text]  
  • Shishodia, S., Majumdar, S., Banerjee, S., Aggarwal, B. B. (2003). Ursolic Acid Inhibits Nuclear Factor-{kappa}B Activation Induced by Carcinogenic Agents through Suppression of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1. Cancer Res. 63: 4375-4383 [Abstract] [Full Text]  
  • Han, S.-J., Ko, H.-M., Choi, J.-H., Seo, K. H., Lee, H.-S., Choi, E.-K., Choi, I.-W., Lee, H.-K., Im, S.-Y. (2002). Molecular Mechanisms for Lipopolysaccharide-induced Biphasic Activation of Nuclear Factor-kappa B (NF-kappa B). J. Biol. Chem. 277: 44715-44721 [Abstract] [Full Text]  
  • Danks, L, Sabokbar, A, Gundle, R, Athanasou, N A (2002). Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis 61: 916-921 [Abstract] [Full Text]  
  • Kim, B.-C., Kim, H.-T., Mamura, M., Ambudkar, I. S., Choi, K.-S., Kim, S.-J. (2002). Tumor Necrosis Factor Induces Apoptosis in Hepatoma Cells by Increasing Ca2+ Release from the Endoplasmic Reticulum and Suppressing Bcl-2 Expression. J. Biol. Chem. 277: 31381-31389 [Abstract] [Full Text]  
  • Kilpatrick, L. E., Lee, J. Y., Haines, K. M., Campbell, D. E., Sullivan, K. E., Korchak, H. M. (2002). A role for PKC-delta and PI 3-kinase in TNF-alpha -mediated antiapoptotic signaling in the human neutrophil. Am. J. Physiol. Cell Physiol. 283: C48-C57 [Abstract] [Full Text]  
  • Chen, F., Bower, J., Leonard, S. S., Ding, M., Lu, Y., Rojanasakul, Y., Kung, H.-f., Vallyathan, V., Castranova, V., Shi, X. (2002). Protective Roles of NF-kappa B for Chromium(VI)-induced Cytotoxicity Is Revealed by Expression of Ikappa B Kinase-beta Mutant. J. Biol. Chem. 277: 3342-3349 [Abstract] [Full Text]  
  • Browne, E. P., Wing, B., Coleman, D., Shenk, T. (2001). Altered Cellular mRNA Levels in Human Cytomegalovirus-Infected Fibroblasts: Viral Block to the Accumulation of Antiviral mRNAs. J. Virol. 75: 12319-12330 [Abstract] [Full Text]  
  • Gilbert, L., He, X., Farmer, P., Rubin, J., Drissi, H., van Wijnen, A. J., Lian, J. B., Stein, G. S., Nanes, M. S. (2002). Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha. J. Biol. Chem. 277: 2695-2701 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs